May 13, 2013
Associated PressThe Supreme Court has sustained Monsanto Co.'s claim that an Indiana farmer violated the company's patents on soybean
seeds that are resistant to its weed-killer.
More
April 25, 2013
Bloomberg NewsEli Lilly and Co. is seeking to revoke a patent held by a Johnson & Johnson unit, arguing at a London court it might delay
availability of a potential treatment for Alzheimer’s disease.
More
March 25, 2013
Associated PressFederal regulators are pressing the Supreme Court to stop big pharmaceutical corporations from paying generic drug competitors
to delay releasing their cheaper versions of brand-name drugs. They argue these deals deny American consumers, usually for
years, steep price declines.
More
February 19, 2013
Associated PressThe U.S. Supreme Court appeared likely Tuesday to side with Monsanto Co. in its claim that an Indiana farmer violated the
company's patents on soybean seeds that are resistant to its weed-killer.
More
February 18, 2013
Associated PressThe court case poses the question of an Indiana farmer's actions violated the patent rights held by Monsanto, which developed
seeds that survive when farmers spray their fields with Roundup weed-killer. The seeds dominate agriculture, including in
Indiana, where more than 90 percent of soybeans are Roundup Ready.
More
November 10, 2012
Chris O'MalleyUniversities that once focused on faculty inventions now are encouraging students to pursue patents. Last year, 355 Purdue
University students filed a patent, a 62-percent jump from 218 student-filed patents the previous year.
More
October 2, 2012
The unsuccessful lawsuit filed by a subsidiary of Belgium-based Bayer Bioscience claimed that insect-resistant corn products
from affiliates of Dow AgroSciences violated two of its patents.
More
September 28, 2012
The lawsuit, filed in December 2010 by Bayer CropScience SA, charged that Indianapolis-based Dow AgroSciences' herbicide-tolerance
technology infringed one of its patents.
More
January 5, 2012
Bloomberg NewsEli Lilly and Co. has sued Biogen Idec Inc. in a London court to revoke a European patent on a potential treatment for immune-system
diseases.
More
December 24, 2011
Eli Lilly and Co. lost patent protection on its $5-billion-a-year best-seller Zyprexa in October, plunging the company into
the long-awaited zone of uncertainty that it calls “Years YZ.”
More
November 26, 2011
Kristin Jones / Special to IBJFor Indiana's life sciences sector, the change both raises hopes and creates challenges for continued growth.
More
November 11, 2011
Scott OlsonThe Indianapolis-based pharmaceutical firm claims an Australian veterinary clinic is infringing on its Comfortis flea medication's
trademark by reselling it to U.S. consumers online.
More
October 27, 2011
Bloomberg NewsBorgWarner Inc., the world’s biggest maker of automatic-transmission parts for vehicles, filed a lawsuit accusing Cummins
Inc. of infringing on three patents for a titanium wheel used in engine turbochargers.
More
October 27, 2011
IBJ StaffOn Oct. 24, the U.S. Food and Drug Administration approved the first generic versions of Eli Lilly and Co.’s best-seller,
ending 15 years of highly lucrative sales.
More
October 24, 2011
J.K. WallLilly's patent-loss challenges—the biggest of which takes effect today—will force the company to rely even more
on its 1,300 Indiana vendors.
More
September 10, 2011
Bloomberg NewsThe legislation would fundamentally alter the way patents are reviewed and mark the biggest change to U.S. patent law since
at least 1952.
More
July 25, 2011
J.K. WallRemember Effient? The blood thinner that was once Eli Lilly and Co.’s greatest post-Zyprexa hope and then, after a slow
launch, was dismissed as an abject failure? Well, it’s turning out to defy both predictions.
More
June 23, 2011
Bloomberg NewsThe U.S. government needs to open its borders to attract and retain talented scientists for drugmakers to employ, Eli Lilly
& Co. CEO John Lechleiter plans to tell a technology conference Thursday.
More
May 18, 2011
Bloomberg NewsThe annual growth rate in spending on drugs may be cut in half over the next five years as people opt for less expensive generic
medicines over brand-name treatments, a health-care research group said Wednesday, highlighting the challenge pharmaceutical
firms like Eli Lilly and Co. are facing.
More
April 26, 2011
Bloomberg NewsGenzyme Corp., the drugmaker bought by Sanofi-Aventis SA this month, sued Zimmer Holdings Inc. and Anika Therapeutics Inc.
alleging the companies’ treatments for arthritic knee pain infringe a patent.
More
April 9, 2011
J.K. WallThe Indiana University School of Medicine has licensed a pediatric psychiatrist's patent on
an alcohol-dependency drug that the doctor discovered improves the language and social skills of autism patients. IU has licensed
the patent to Indianapolis-based Confluence Pharmaceuticals Inc.
More
March 16, 2011
J.K. WallEli Lilly and Co. CEO John Lechleiter visited Japan last week—three days before the massive earthquake—to deliver
his tried-and-true message: Drug companies need to reinvent invention, governments needs to support innovation, and Lilly
will be just fine after it has sustained the damage of the next three years.
More
March 1, 2011
Associated PressDow Chemical Co.'s agricultural division said it has taken the next step toward gaining international patent rights for
its new strain of genetically engineered corn that it says will help farmers battle a new strain of "super-weeds."
More
February 28, 2011
Associated PressCongress has been trying for well over a decade to rewrite patent law, only to be thwarted by the many interested parties.
More
February 26, 2011
Bob Kronemyer / Special to IBJFilching ranges from crude to highly sophisticated, experts say.
More
From overarching to progress? Never mind.
Every one who has been scammed by these people may be interested to know that we got our money back from them. It took some time and a 'special approach', but it worked. We are now on the way to stopping their activities. Anyone wishing to participate in this action is welcome. Please make contact through our website www.laterelle.com Peter Clutton
Lou, I had mouth watering just by reading your review. I recently was in this restaurant with family and friends and I can tell you THIS IS A REAL TASTE OF MEXICO. Forget about those restaurants that claim being "authentic Mexican food". Don Gusto P.J. has the most Authentic regional taste of Mexican food. My wife is from Mexico City and she can tell this was like home. It's a small place, but the greatness of Don Gusto P.J. is the real authentic taste of Mexican Food and the friendly service. By the way, this is a family owned and operated business. Great review, Lou!
With the way this lovely couple met, it's amazing their business failed. I mean, I'm young and easy going but I wouldn't trust her or him as far as I could throw them
You agreed to make a law to take peoples children out of there home for any little thing I feel like if there is no abuse no violence no neglect no molestation you shouldn't take children from their homes if there not in danger or harm people that do drugs shouldnt loose their kids because they have an addiction they should be helped in wich way they can taking children out of there homes is not the answer nor the solution 90% of time you make the situation worser than what it is do you think that it's fair to the children putting them through this who would even ever come up with this its unfair one of the presidents used marjuana did they take his children or freedom the law is crooked and its alot of dirty people taking advantage of it god isn't unfair to us so we shouldnt be unfair to others something needs to be done about now not later this world is corrupt and the people in it this is a disgrace to man kind I'm going to pray for justice